Literature DB >> 26042632

Institutional Review Boards: Purpose and Challenges.

Christine Grady1.   

Abstract

Institutional review boards (IRBs) or research ethics committees provide a core protection for human research participants through advance and periodic independent review of the ethical acceptability of proposals for human research. IRBs were codified in US regulation just over three decades ago and are widely required by law or regulation in jurisdictions globally. Since the inception of IRBs, the research landscape has grown and evolved, as has the system of IRB review and oversight. Evidence of inconsistencies in IRB review and in application of federal regulations has fueled dissatisfaction with the IRB system. Some complain that IRB review is time-consuming and burdensome without clear evidence of effectiveness at protecting human subjects. Multiple proposals have been offered to reform or update the current IRB system, and many alternative models are currently being tried. Current focus on centralizing and sharing reviews requires more attention and evidence. Proposed changes to the US federal regulations may bring more changes. Data and resourcefulness are needed to further develop and test review and oversight models that provide adequate and respectful protections of participant rights and welfare and that are appropriate, efficient, and adaptable for current and future research.

Entities:  

Mesh:

Year:  2015        PMID: 26042632      PMCID: PMC4631034          DOI: 10.1378/chest.15-0706

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  33 in total

1.  OHRP compliance oversight letters: an update.

Authors:  Carol Weil; Lisa Rooney; Patrick McNeilly; Karena Cooper; Kristina Borror; Paul Andreason
Journal:  IRB       Date:  2010 Mar-Apr

2.  Pruning the regulatory tree.

Authors:  Scott Kim; Peter Ubel; Raymond De Vries
Journal:  Nature       Date:  2009-01-29       Impact factor: 49.962

3.  Ethical support for surfactant, positive pressure, and oxygenation randomized trial (SUPPORT).

Authors:  Jonathan M Fanaroff
Journal:  J Pediatr       Date:  2013-07-23       Impact factor: 4.406

4.  Trials and tribulations.

Authors:  Susan Gilbert
Journal:  Hastings Cent Rep       Date:  2008 Mar-Apr       Impact factor: 2.683

Review 5.  Grinding to a halt: the effects of the increasing regulatory burden on research and quality improvement efforts.

Authors: 
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

Review 6.  Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.

Authors:  Devon K Check; Kevin P Weinfurt; Carrie B Dombeck; Judith M Kramer; Kathryn E Flynn
Journal:  Clin Trials       Date:  2013-05-10       Impact factor: 2.486

7.  Central institutional review board review for an academic trial network.

Authors:  Petra Kaufmann; P Pearl O'Rourke
Journal:  Acad Med       Date:  2015-03       Impact factor: 6.893

Review 8.  A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn.

Authors:  Lura Abbott; Christine Grady
Journal:  J Empir Res Hum Res Ethics       Date:  2011-03       Impact factor: 1.742

9.  Costs and benefits of the national cancer institute central institutional review board.

Authors:  Todd H Wagner; Christine Murray; Jacquelyn Goldberg; Jeanne M Adler; Jeffrey Abrams
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

10.  How do we know that research ethics committees are really working? The neglected role of outcomes assessment in research ethics review.

Authors:  Carl H Coleman; Marie-Charlotte Bouësseau
Journal:  BMC Med Ethics       Date:  2008-03-28       Impact factor: 2.652

View more
  23 in total

1.  Cutting Through the "Gray Area": An Analysis of the IBC Regulatory Oversight of Applications of CRISPR Technology in Clinical Research.

Authors:  Westley F Weiss
Journal:  Ther Innov Regul Sci       Date:  2021-05-18       Impact factor: 1.778

2.  Filling the Regulatory Gap: Potential Role of Institutional Review Boards in Promoting Consideration of Sex as a Biological Variable.

Authors:  Korrina A Duffy; Tracy A Ziolek; C Neill Epperson
Journal:  J Womens Health (Larchmt)       Date:  2020-04-08       Impact factor: 2.681

3.  Expert Perspectives on Oversight for Unregulated mHealth Research: Empirical Data and Commentary.

Authors:  Laura M Beskow; Catherine M Hammack-Aviran; Kathleen M Brelsford; P Pearl O'Rourke
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

4.  Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool.

Authors:  Lisa Rooney; Laura Covington; Andrea Dedier; Birdena Samuel
Journal:  J Empir Res Hum Res Ethics       Date:  2019-04       Impact factor: 1.742

Review 5.  Clinical Trials and the Role of the Oncology Clinical Trials Nurse.

Authors:  Elizabeth A Ness; Cheryl Royce
Journal:  Nurs Clin North Am       Date:  2017-03       Impact factor: 1.208

Review 6.  Comparing human and mouse salivary glands: A practice guide for salivary researchers.

Authors:  C L Maruyama; M M Monroe; J P Hunt; L Buchmann; O J Baker
Journal:  Oral Dis       Date:  2018-04-24       Impact factor: 3.511

Review 7.  How Does Research Start?

Authors:  Bernadette Capili
Journal:  Am J Nurs       Date:  2020-10       Impact factor: 2.577

8.  Ethical issues related to clinical research and rare diseases: 15th Gordon L. Snider Critical Issues Workshop, April 1, 2016, Bethesda, Maryland.

Authors:  Marilyn Coors; Larry Bauer; Kelly Edwards; Karen Erickson; Aaron Goldenberg; John Goodale; Kenneth Goodman; Christine Grady; David Mannino; Adam Wanner; Todd Wilson; Mark Yarborough; Maryan Zirkle
Journal:  Transl Sci Rare Dis       Date:  2017-12-18

9.  IRB Process Improvements: A Machine Learning Analysis.

Authors:  Kimberly Shoenbill; Yiqiang Song; Nichelle L Cobb; Marc K Drezner; Eneida A Mendonca
Journal:  J Clin Transl Sci       Date:  2017-04-26

10.  Understanding Constraints and Enablers of Turnaround Time for Ethics Review: The Case of Institutional Review Boards in Tanzania.

Authors:  Mwifadhi Mrisho; Zaynab Essack
Journal:  J Empir Res Hum Res Ethics       Date:  2021-06-28       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.